Kaneka Probiotics takes on precision probiotics

This content item was originally published on www.nutraingredients-usa.com, a William Reed online publication.

By Danielle Masterson

- Last updated on GMT

Related tags Probiotics Gut health microbiome Kaneka Supplyside west Ibs

The company is seeing success in recent studies and are ramping up for an exciting new study in women’s health.

Jordi Riera, Chief Business Development Manager Kaneka Probiotics, detailed two studies utilizing precision probiotics. The first study focused on probiotic strains on two L. plantarum strains as well as P. acidilactici, which were shown to produce postbiotic molecules including acetate, polyP, ACh and antimicrobial compounds (potentially bacteriocins) against IBS-associated microorganisms. This unique combination of postbiotics could explain the clinically beneficial effects of the probiotic mix in IBS subjects.

“The mechanisms achieved are significant results in IBS quality of life,” said Riera. “The key takeaway is that the customers that took the product really notice the effects.”

Riera also detailed another Kaneka study that assessed the efficacy of probiotics in improving lactose intolerance symptoms compared with placebo after 8 weeks of treatment. The probiotic blend i3.1 is a blend that contains three  live strains - Pediococcus acidilactici CECT 7483, Lactobacillus plantarum CECT 7484 and Lactobacillus plantarum CECT 7485. 

“Symptoms of lactose intolerance are very close to IBS, same discomfort, diarrhea, anxiety, and bad quality of life and that one achieved positive results.”​ Riera added that the probiotics were effective in reducing lactose intolerance symptoms.

Kaneka also has more research in the pipeline, with an exciting new study that will be disclosed soon. “I can tell you that it will be the world's first probiotic  with a clinical trial on menopause,"​ Riera said. "Menopause is the next big issue.”

Related news

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

New Study for Female Athletes

New Study for Female Athletes

Content provided by Gencor | 19-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

Related suppliers

Follow us


View more